The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies

MJ Satlin, SG Jenkins, TJ Walsh - Clinical infectious diseases, 2014 - academic.oup.com
Carbapenem-resistant Enterobacteriaceae (CRE) are emerging global pathogens. The
spread of CRE to transplant recipients and patients with hematologic malignancies has …

Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic …

SM Pouch, MJ Satlin - Virulence, 2017 - Taylor & Francis
Carbapenem-resistant Enterobacteriaceae (CRE) are a major global public health concern
and pose a serious threat to immunocompromised hosts, particularly patients with …

Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies

MJ Satlin, DP Calfee, L Chen, KA Fauntleroy… - Leukemia & …, 2013 - Taylor & Francis
Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent pathogens.
However, little is known about their emergence in patients with hematologic malignancies …

[HTML][HTML] Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

CC Sheu, YT Chang, SY Lin, YH Chen… - Frontiers in …, 2019 - frontiersin.org
Carbapenems are considered as last-resort antibiotics for the treatment of infections caused
by multidrug-resistant Gram-negative bacteria. With the increasing use of carbapenems in …

[HTML][HTML] Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?

M Yamamoto, AE Pop-Vicas - Critical Care, 2014 - Springer
The global spread of carbapenem-resistant Enterobacteriaceae (CRE) is increasingly
becoming a major challenge in clinical and public health settings. To date, the treatment for …

Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United …

MJ Satlin, L Chen, G Patel… - Antimicrobial agents …, 2017 - Am Soc Microbiol
ABSTRACT Although the New York/New Jersey (NY/NJ) area is an epicenter for
carbapenem-resistant Enterobacteriaceae (CRE), there are few multicenter studies of CRE …

Multidrug‐resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin‐resistant Enterococcus: Three major threats to hematopoietic stem cell …

MJ Satlin, TJ Walsh - Transplant Infectious Disease, 2017 - Wiley Online Library
Hematopoietic stem cell transplant (HSCT) recipients are uniquely threatened by the
emergence of multidrug‐resistant (MDR) bacteria because these patients rely on immediate …

Therapeutic options for carbapenem-resistant Enterobacteriaceae infections

EM Trecarichi, M Tumbarello - Virulence, 2017 - Taylor & Francis
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically
increased and represents an important threat to global health. The optimal therapeutic …

[HTML][HTML] Management of carbapenem-resistant Enterobacteriaceae infections

E Durante-Mangoni, R Andini, R Zampino - Clinical Microbiology and …, 2019 - Elsevier
Background Carbapenem resistance is defined as in vitro non-susceptibility to any
carbapenem and/or documented production of a carbapenemase. This feature has rapidly …

Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia

PD Tamma, KE Goodman, AD Harris… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background. Carbapenem-resistant Enterobacteriaceae (CRE) are associated with
considerable mortality. As mechanisms of carbapenem resistance are heterogeneous, it is …